Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

14.71
Delayed Data
As of Dec 08
 +0.67 / +4.77%
Today’s Change
7.73
Today|||52-Week Range
15.05
+27.91%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close14.04
Today’s open14.31
Day’s range13.76 - 14.80
Volume43,454
Average volume (3 months)74,804
Market cap$317.3M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+12.50%
Earnings growth (this year)-3.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.82%
P/E ratio--
Price/Sales3.99
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.25-2.62%
IMMUImmunomedics Inc+0.08+2.25%
CLDXCelldex Therapeutics...-0.02-0.53%
VCYTVeracyte Inc+0.18+2.43%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$62.8M
Annual profit (last year)-$24.5M
Net profit margin-38.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO &
Executive Class III Director
Peter James Wrighton-Smith
Chief Operations Officer
Peter Edwardson
Corporate headquarters
Abingdon, Oxfordshire

Forecasts


Search for Jobs